Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial have?
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial has 4 citations in the OpenAlex counts ScholarIQ stores.
When was Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial published?
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial has 2026 year in the ScholarIQ index.
What is the open-access status of Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial?
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial has closed oa status in the ScholarIQ index.
What is the DOI of Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial?
The DOI for Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial is on the source record.
What is the PMID of Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial?
The PMID for Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial is on the source record.
What is the OpenAlex record for Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial?
The OpenAlex for Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial is on the source record.